This is an application for a renewal of a NIDA sponsored K02 Independent Scientist Award. The candidate, Dr. Sabita Roy holds a Ph.D. degree from the University of Kansas, Lawrence and is a Professor in the Department of Pharmacology, University of Minnesota. She is currently funded by two independent grants;DA 12104 from NIDA/NIH-to study the effect of morphine on immune cells and DA 11806 from NIDA/NIH-to investigate the role mu opioid receptor on stress induced immunomodulation. This award will provide the candidate with release time to expand her research skills and enhance her ability for scientific investigations and mentoring. The long-term research goal of the candidate is to explore the molecular and cellular mechanism involved in morphine induced immunosupression and increased susceptibility to opportunistic infections such as S. pneumonia and HIV/AIDS. The candidate has already demonstrated using a murine model of S. pneumonia that morphine treatment significantly increases mortality and morbidity and accelerates disease progression. The major goal of the current application is to train in HIV/AIDS research as it relates to drug abuse and incorporate this line of research into her ongoing research projects. The training in HIV research will allow the candidate in future research to identify mechanisms by which drugs of abuse modulate HIV replication and or latency and if secondary opportunistic infection alter these processes. To achieve this goal release time will be utilized for mini sabbaticals and undertake training in HIV/AIDS research in the labs of eminent HIV/AIDS researchers. The KO 2 Award will facilitate this by relieving considerable amount of teaching and administrative duties. This plan has the full support of the Department of Pharmacology and the University of Minnesota.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Scientist Development Award - Research (K02)
Project #
Application #
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Avila, Albert
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
Schools of Medicine
United States
Zip Code
Koodie, Lisa; Yuan, Hongyan; Pumper, Jeffery A et al. (2014) Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice. Am J Pathol 184:1073-1084
Ninkovi?, Jana; Roy, Sabita (2013) Role of the mu-opioid receptor in opioid modulation of immune function. Amino Acids 45:9-24
Meng, Jingjing; Yu, Haidong; Ma, Jing et al. (2013) Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS One 8:e54040
Dutta, Raini; Krishnan, Anitha; Meng, Jingjing et al. (2012) Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae. J Neurosci 32:9917-30
Chanakira, Alice; Dutta, Raini; Charboneau, Richard et al. (2012) Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFR-? and VEGFR-2 expression. Am J Physiol Heart Circ Physiol 302:H1173-84
Ninkovi?, Jana; Roy, Sabita (2012) Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms. Am J Pathol 180:1068-79
Roy, Sabita (2011) Drugs of abuse effects on immunity and microbial pathogenesis. J Neuroimmune Pharmacol 6:435-8
Roy, Sabita; Ninkovic, Jana; Banerjee, Santanu et al. (2011) Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol 6:442-65
Wang, Jinghua; Ma, Jing; Charboneau, Rick et al. (2011) Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling. J Biol Chem 286:10225-32
Das, Subhas; Kelschenbach, Jennifer; Charboneau, Richard et al. (2011) Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids. J Biol Chem 286:29806-17

Showing the most recent 10 out of 29 publications